HealthLinx's OvPlex Test Posts Weak Sales Numbers Despite Year of Big Distribution Gains
December 03, 2010
HealthLinx's OvPlex Test Posts Weak Sales Numbers Despite Year of Big Distribution Gains
With its recent deal for South Korean distribution, the company has agreements for OvPlex in the UK, Australia, Singapore, Israel, and South Korea, but sales of the test still lag well behind expectations.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.